For the quarter ending 2026-03-28, CRL made $995,830K in revenue. -$14,843K in net income. Net profit margin of -1.49%.
| Income Statement | 2026-03-28 | 2025-12-27 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Total revenue | 995,830 | 994,227 | 1,004,852 | 1,032,135 |
| Cost of revenue (excluding amortization of intangible assets)-Service | 608,907 | 579,821 | 572,635 | 584,876 |
| Cost of revenue (excluding amortization of intangible assets)-Product | 92,259 | 104,722 | 93,425 | 90,192 |
| Selling, general and administrative | 159,422 | 196,136 | 177,589 | 191,549 |
| Amortization of intangible assets | 15,345 | 21,014 | 27,404 | 65,384 |
| Intangible asset impairment | - | 334,724* | - | - |
| Goodwill impairment | - | 41,250* | - | - |
| Operating income (gain) | 119,897 | -283,440 | 133,799 | 100,134 |
| Interest income | 1,033 | 1,017 | 1,422 | 1,097 |
| Interest expense | 26,742 | 23,775 | 25,403 | 29,967 |
| Other (expense) income, net | -124,130 | 12,099 | -22,618 | 154 |
| Income (loss) before income taxes | -29,942 | -294,099 | 87,200 | 71,418 |
| Provision (benefit) for income taxes | -15,140 | -17,809 | 31,644 | 18,725 |
| Net income (loss) | -14,802 | -276,290 | 55,556 | 52,693 |
| Less net income attributable to noncontrolling interests | 41 | 265 | 1,134 | 367 |
| Net income (loss) attributable to common shareholders | -14,843 | -276,555 | 54,422 | 52,326 |
| Less adjustment of redeemable noncontrolling interests | - | - | 0 | 0 |
| Less incremental dividends attributed to noncontrolling interest holders | - | 0 | 0 | 0 |
| Net income (loss) available to charles river laboratories international, inc. common shareholders | - | -276,555 | 54,422 | 52,326 |
| Basic EPS | -0.3 | -5.619 | 1.11 | 1.06 |
| Diluted EPS | -0.3 | -5.683 | 1.1 | 1.06 |
| Basic Average Shares | 48,951,000 | 49,217,000 | 49,213,000 | 49,149,000 |
| Diluted Average Shares | 48,951,000 | 48,661,000 | 49,426,000 | 49,316,000 |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)